Session 5: Global Theranostics: Opportunities and Challenges
24 September 2026
Global Theranostics: Implementing WHA 78.13 — Where to from here?
Diana Paez
Why radiopharmaceuticals need a different regulatory pathway than regular pharmaceuticals?
Simone Leyden
Theranostic Approaches: CHallenges and opportunities from training to practice
Munir Ghesani
Theranostic research Trials: How to follow the SLU Experience
Medhat Osman
Precision and Protection: Radiation Safety in Radionuclide Therapy
Soma Somanesan
Lost in Regulation: How Patients Pay the Price for Complexity
Alice Viana
Scaling patient access to theranostics
Marwa Hakkam
coffee break
10:45AM - 11:00AM
Session 6: Novel Targets in the Oncology Landscape
24 September 2026
Experience using FAP radionuclide therapy
Richard Baum
Imaging targeting Avβ6‑integrin Therapy targeting αvβ6‑integrin
Mohamed Elkanawaty
Michael Kreissl
Advancing Radiotherapeutic aspects of Renal Cell Cancer
Aviral Singh
Update on TRL in Bladder Cancer
Ralph Wirtz
Breast Cancer: Is it the Next Theranostic Paradigm?
Ralph Wirtz
Rhenium-188 in Dermatologic Oncology: Efficacy, Safety, and Practical Considerations
Mariela Agolti
Andrei Iagaru
Lunch break
1:00PM - 2:00PM
Session 7: RLT in the Multidisciplinary Era
24 September 2026
Shifting Paradigms in NET and Prostate Cancer: An Oncologist’s Perspective
Oliver Sartor
Combination trials RLT + Oncology
Elcin Zan
The Clinical Rationale for Radioligand Plus External Beam Radiotherapy Combinations
Katherine Vallis
DNA Damage Response Inhibitors in Combination with RLT
Sze Ting
From a UROLOGist PERSPECTIVE
Coffee break
3:30PM - 04:00PM
Session 8: Practical RLT Considerations
24 September 2026
Clinical Challenges in Radionuclide Therapy: Lessons from Practice
Fadi Khreish
Management of accidental extravasation of Lu-177–based radioligands
Camilo Garcia
Rechallenge ¹⁷⁷Lu-PSMA RLT in patients with metastatic castration-resistant prostate cancer
John Koutsikos
Establishing a Theranostic Center: How we did it
Medhat Osman
Clinical Pearls in Theranostics Practice: Why Proper Training matters
Patricia Bautista
Through the Patient’s Eyes: Experiences with radionuclide Therapy
Josh Mailman